# Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars

> **NCT07561216** · NA · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 50 (estimated)

## Conditions studied

- Dental Caries

## Interventions

- **OTHER:** giomer
- **OTHER:** RMGI

## Key facts

- **NCT ID:** NCT07561216
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-06
- **Final completion:** 2027-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07561216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07561216, "Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07561216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*